Standing Order
Pfizer Inc.

Dashboard

Pfizer Inc.

PFENYSE

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$156B
Price$27.4052w $23.29 – $30.79
Conviction3/ 5
Revenue (TTM)$63.6B
Revenue growth YoY+1.3%
P/E (trailing)38.7
Gross margin73.4%
Operating margin23.8%
Net margin6.3%
52w price change+14.3%
Next earningsFeb 2, 2027

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 16
    Ownership changeSEC

    Form 4 insider transaction filing by Pfizer executive or director.

  • Nov 3
    Ownership changeSEC

    Pfizer Inc. Form 4 insider transaction filing dated 2026-11-03.

  • Nov 3
    LeadershipSEC

    8-K reports changes in directors or officers under item 5.02.

  • Nov 3
    Financial resultsSEC

    Pfizer files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Nov 2
    DealFederal award

    Pfizer awarded $11.11B DoD contract for COVID-19 vaccine production.

    $11.1B
  • Oct 16
    Ownership changeSEC

    Pfizer Inc. filed SEC Form 4 reporting an insider transaction.

  • Oct 14
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Oct 1
    Ownership changeSEC

    Form 4 insider transaction filing dated 2026-10-01.

  • Sep 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 29
    Ownership changeSEC

    Form 4 insider transaction filing for Pfizer Inc.

  • Sep 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing dated 2026-09-29.

  • Sep 16
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Sep 1
    Ownership changeSEC

    SEC Form 4 insider ownership report filed.

  • Aug 27
    DealFederal award

    Pfizer awarded $11.11B DoD contract for COVID-19 vaccine production (award W15QKN21C0012).

    $11.1B
  • Aug 17
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership.

  • Aug 12
    Ownership changeSEC

    SEC Form 4 insider transaction filing reporting change in beneficial ownership.

  • Aug 6
    Ownership changeSEC

    Pfizer insider filed SEC Form 4 reporting transaction.

Not financial advice — research and opinion only. Disclosures